These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 2878725
21. Neuroleptic malignant syndrome: a subtype of lethal catatonia? Ahuja N, Nehru R. Acta Psychiatr Scand; 1990 Nov; 82(5):398. PubMed ID: 1980785 [No Abstract] [Full Text] [Related]
23. [Clinical aspects, pathogenesis and treatment of neuroleptic malignant syndrome]. Sep-Kowalikowa B. Psychiatr Pol; 1989 Nov; 23(1):44-53. PubMed ID: 2573100 [No Abstract] [Full Text] [Related]
24. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Addonizio G, Susman VL. J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837 [Abstract] [Full Text] [Related]
25. Lethal catatonia and neuroleptic malignant syndrome. Greedharry D, Bowen R. Can J Psychiatry; 1993 Apr; 38(3):236-7. PubMed ID: 8098989 [No Abstract] [Full Text] [Related]
26. Neuroleptic-induced catatonia: neuroleptic malignant syndrome? de Leon J, Saiz-Ruiz J, Alonso-Abolafia A, Pico-Soler E, Munoz-Ruata J, de la Serna I. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Apr; 14(1):129-36. PubMed ID: 1967846 [Abstract] [Full Text] [Related]
27. Risk factors for neuroleptic malignant syndrome. Francis A, Chandragiri S, Petrides G. Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151 [No Abstract] [Full Text] [Related]
28. Lethal catatonia and neuroleptic malignant syndrome. Chiang WK, Herschman Z. Crit Care Med; 1992 Nov; 20(11):1622-3. PubMed ID: 1424709 [No Abstract] [Full Text] [Related]
30. Fatal hyperthermia syndrome. Am J Psychiatry; 1991 Oct 18; 148(10):1411-2. PubMed ID: 1680297 [No Abstract] [Full Text] [Related]
31. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry; 1989 Sep 18; 146(9):1240-2. PubMed ID: 2569842 [No Abstract] [Full Text] [Related]
32. [Neuroleptic malignant syndrome in users of risperidone]. Bonte-Mineur F, Geerlings CJ, Rietveld AP. Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595 [No Abstract] [Full Text] [Related]
33. [Neuroleptic malignant syndrome]. Dahm JB, Trenckmann U. Med Klin (Munich); 1991 Nov 15; 86(11):601-4. PubMed ID: 1685215 [No Abstract] [Full Text] [Related]
34. Catatonia and neuroleptic malignant syndrome. Francis A, Yacoub A. Ann Clin Psychiatry; 2008 Nov 15; 20(4):231; author reply 232-3. PubMed ID: 19034757 [No Abstract] [Full Text] [Related]
35. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature]. Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J. Encephale; 2001 Nov 15; 27(3):213-6. PubMed ID: 11488250 [Abstract] [Full Text] [Related]
36. Lethal catatonia. Ljubisavljevic V. Aust N Z J Psychiatry; 2002 Aug 15; 36(4):563-4. PubMed ID: 12169165 [No Abstract] [Full Text] [Related]
37. [Neuroleptic malignant syndrome]. Murak E. Psychiatr Pol; 1995 Aug 15; 29(3):349-58. PubMed ID: 7652088 [Abstract] [Full Text] [Related]